Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

被引：0
|
作者：
Ren Sun
Liya Wang
机构：
[1] Swedish University of Agricultural Sciences,Department of Anatomy, Physiology, and Biochemistry
[2] The Biomedical Centre,undefined
来源：
BMC Microbiology | / 13卷
关键词：
Growth inhibition; 6-thioguanine; Trifluorothymidine; Hypoxanthine guanine phosphoribosyl transferase; Thymidine kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [41] Computational Screening of FDA-Approved Hepatitis C Drugs for Inhibition of VEGFR2 in Liver Cancer
    Roney, Miah
    Issahaku, Abdul Rashid
    Tufail, Nasir
    Wilhelm, Anke
    Aluwi, Mohd Fadhlizil Fasihi Mohd
    CHEMISTRYSELECT, 2024, 9 (35):
  • [42] Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs
    Whitehead, Clarissa A.
    Nguyen, Hong P. T.
    Morokoff, Andrew P.
    Luwor, Rodney B.
    Paradiso, Lucia
    Kaye, Andrew H.
    Mantamadiotis, Theo
    Stylli, Stanley S.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (06): : 1406 - 1418
  • [43] The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo
    Alburquerque-Gonzalez, Begona
    Bernabe-Garcia, Angel
    Bernabe-Garcia, Manuel
    Ruiz-Sanz, Javier
    Lopez-Calderon, Fernando Feliciano
    Gonnelli, Leonardo
    Banci, Lucia
    Pena-Garcia, Jorge
    Luque, Irene
    Nicolas, Francisco Jose
    Cayuela-Fuentes, Maria Luisa
    Luchinat, Enrico
    Perez-Sanchez, Horacio
    Montoro-Garcia, Silvia
    Conesa-Zamora, Pablo
    CANCERS, 2021, 13 (04) : 1 - 22
  • [44] Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
    Pirzada, Rameez Hassan
    Haseeb, Muhammad
    Batool, Maria
    Kim, MoonSuk
    Choi, Sangdun
    CELLS, 2021, 10 (05)
  • [45] Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells
    Ko, Meehyun
    Jeon, Sangeun
    Ryu, Wang-Shick
    Kim, Seungtaek
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1403 - 1408
  • [46] FACTORS INFLUENCING GROWTH INHIBITION OF MYCOPLASMA PNEUMONIAE BY IMMUNE SERA
    FERNALD, GW
    CLYDE, WA
    DENNY, FW
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1967, 126 (01): : 161 - &
  • [47] Extracting functional groups of ALLINI to design derivatives of FDA-approved drugs: Inhibition of HIV-1 integrase
    Kalathiya, Umesh
    Padariya, Monikaben
    Baginski, Maciej
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2018, 65 (04) : 594 - 607
  • [48] A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus
    Hirano, Minato
    Sakurai, Yasuteru
    Urata, Shuzo
    Kurosaki, Yohei
    Yasuda, Jiro
    Yoshii, Kentaro
    ANTIVIRAL RESEARCH, 2022, 200
  • [49] Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses
    Machado-Vieira, Rodrigo
    Quevedo, Joao
    Shahani, Lokesh
    Soares, Jair C.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2021, 43 (05) : 462 - 464
  • [50] SURVEY OF MYCOPLASMA-PNEUMONIAE INFECTIONS BY GROWTH-INHIBITION TEST
    SZABO, N
    ACTA MICROBIOLOGICA HUNGARICA, 1984, 31 (03): : 251 - 251
12345